Healthcare provider profile · identity verified

Rajesh Kumar Singh, M.D.

Internal Medicine · CHESTERFIELD, MO · NPI 1083841902

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	498	53
Levothyroxine Sodium	Levothyroxine Sodium	358	48
Atorvastatin Calcium	Atorvastatin Calcium	342	39
Eliquis	Apixaban	293	30
Sertraline Hcl	Sertraline Hcl	278	27
Pantoprazole Sodium	Pantoprazole Sodium	269	31
Metoprolol Tartrate	Metoprolol Tartrate	250	23
Mirtazapine	Mirtazapine	232	31
Gabapentin	Gabapentin	228	21
Metoprolol Succinate	Metoprolol Succinate	202	26
Tamsulosin Hcl	Tamsulosin Hcl	192	20
Trazodone Hcl	Trazodone Hcl	192	36
Lisinopril	Lisinopril	182	23
Potassium Chloride	Potassium Chloride	165	25
Amlodipine Besylate	Amlodipine Besylate	156	30
Quetiapine Fumarate	Quetiapine Fumarate	146	25
Escitalopram Oxalate	Escitalopram Oxalate	140	20
Memantine Hcl	Memantine Hcl	139	17
Losartan Potassium	Losartan Potassium	132	21
Donepezil Hcl	Donepezil Hcl	122	23
Buspirone Hcl	Buspirone Hcl	101	14
Citalopram Hbr	Citalopram Hydrobromide	96	15
Clopidogrel	Clopidogrel Bisulfate	94	12
Carbidopa-Levodopa	Carbidopa/Levodopa	92	14
Divalproex Sodium	Divalproex Sodium	92	16
Venlafaxine Hcl Er	Venlafaxine Hcl	84	suppressed
Xarelto	Rivaroxaban	83	suppressed
Bethanechol Chloride	Bethanechol Chloride	81	suppressed
Tramadol Hcl	Tramadol Hcl	81	25
Pravastatin Sodium	Pravastatin Sodium	79	suppressed
Metformin Hcl	Metformin Hcl	75	suppressed
Famotidine	Famotidine	69	16
Myrbetriq	Mirabegron	69	suppressed
Hydralazine Hcl	Hydralazine Hcl	67	suppressed
Alendronate Sodium	Alendronate Sodium	63	suppressed
Finasteride	Finasteride	62	suppressed
Duloxetine Hcl	Duloxetine Hcl	61	suppressed
Meloxicam	Meloxicam	61	suppressed
Glipizide	Glipizide	60	suppressed
Carvedilol	Carvedilol	59	14
Namzaric	Memantine Hcl/Donepezil Hcl	58	suppressed
Folic Acid	Folic Acid	53	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	12
Latanoprost	Latanoprost	51	suppressed
Simvastatin	Simvastatin	51	suppressed
Loperamide	Loperamide Hcl	48	13
Methenamine Hippurate	Methenamine Hippurate	48	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	44	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	suppressed
Pregabalin	Pregabalin	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	13
Amiodarone Hcl	Amiodarone Hcl	38	suppressed
Omeprazole	Omeprazole	38	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Memantine Hcl Er	Memantine Hcl	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	suppressed
Glimepiride	Glimepiride	36	suppressed
Prednisone	Prednisone	36	11
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Anastrozole	Anastrozole	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	31	suppressed
Torsemide	Torsemide	31	suppressed
Irbesartan	Irbesartan	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	13
Cilostazol	Cilostazol	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Ondansetron Odt	Ondansetron	28	23
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Nystatin	Nystatin	24	13
Januvia	Sitagliptin Phosphate	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Propafenone Hcl	Propafenone Hcl	23	suppressed
Atenolol	Atenolol	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Digoxin	Digoxin	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Cephalexin	Cephalexin	21	16
Mesalamine	Mesalamine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Risperidone	Risperidone	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	15	suppressed
Nyamyc	Nystatin	15	suppressed
Restasis	Cyclosporine	15	suppressed
Topiramate	Topiramate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Lumigan	Bimatoprost	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Baclofen	Baclofen	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Jardiance	Empagliflozin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error